Search
Y-mAbs Therapeutics Inc
YMABAdd to Watchlist
8.610USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
391.22MMarket Cap
LossP/E TTM
Y-mAbs Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
87.69M
3.38%
EPS(YoY)
-0.67
-36.31%
Analyst Rating
2025-09-19
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Y-mAbs Therapeutics Inc?
According to Y-mAbs Therapeutics Inc's FY2024 earnings report, its total revenue reached 87.69M, with a year-on-year change of 3.38.
What are the current assets of Y-mAbs Therapeutics Inc?
According to Y-mAbs Therapeutics Inc's FY2024 earnings report, its current assets were 98.51M, with a year-on-year change of -11.34.
What are the total assets of Y-mAbs Therapeutics Inc?
According to Y-mAbs Therapeutics Inc's FY2024 earnings report, its total assets of Y-mAbs Therapeutics Inc were 119.90M, with a year-on-year change of -6.23.
What are the total liabilities of Y-mAbs Therapeutics Inc?
According to Y-mAbs Therapeutics Inc's FY2024 earnings report, its total liabilities of Y-mAbs Therapeutics Inc were 27.90M, with a year-on-year change of 3.78.
What is the total equity of Y-mAbs Therapeutics Inc?
According to Y-mAbs Therapeutics Inc's FY2024 earnings report, its total equity of Y-mAbs Therapeutics Inc was 92.00M, with a year-on-year change of -8.89.
What is the net financing of Y-mAbs Therapeutics Inc?
According to Y-mAbs Therapeutics Inc's FY2024 earnings report, its net financing of Y-mAbs Therapeutics Inc was 4.31M, with a year-on-year change of 4211.00.
What is the Earnings Per Share (EPS) of Y-mAbs Therapeutics Inc?
According to Y-mAbs Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -0.67, with a year-on-year change of -36.31.
What is the net margin of Y-mAbs Therapeutics Inc?
According to Y-mAbs Therapeutics Inc's FY2024 earnings report, its net profit margin was -33.83, with a year-on-year change of -33.93.
What is the gross margin of Y-mAbs Therapeutics Inc?
According to Y-mAbs Therapeutics Inc's FY2024 earnings report, its gross margin was 82.61, with a year-on-year change of -4.55.
What is the Return on Equity (ROE) of Y-mAbs Therapeutics Inc?
According to Y-mAbs Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -30.74, with a year-on-year change of -50.80.
What is the Return on Assets (ROA) of Y-mAbs Therapeutics Inc?
According to Y-mAbs Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -23.95, with a year-on-year change of -50.49.
What is the operating profit of Y-mAbs Therapeutics Inc?
According to Y-mAbs Therapeutics Inc's FY2024 earnings report, its operating profit was -29.68M, with a year-on-year change of -40.06.